This is a peer-reviewed supplementary table for the article ' Single-arm oncology trials and the nature of external controls arms ' published in the Journal of Comparative Eff

DataCite Commons2026-04-29 更新100

Racial and ethnic diversity in Janus kinase inhibitor alopecia areata clinical trials

临床试验多样性

药物流行病学

Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring alopecia. In June 2022, baricitinib, a Janus kinase (JAK) inhibitor, became the first Federal Drug Administration (FDA) ap

NIAID Data Ecosystem90

Appendix 2. Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials

临床试验多样性

肿瘤学试验

Appendix 2: Study exclusion criteria.

Taylor & Francis Group2024-05-15 更新50